Novartis to review US$600m global media business

GLOBAL - Novartis, the pharmaceutical giant, is gearing up to launch a review of its estimated US$600 million global media business.

by Katherine Levy

Please sign in below or access limited articles a month after free, fast registration.

If you don’t yet have an account, you can register for free to unlock additional content. For full access to everything we offer, view our subscription plans.

Trouble signing in?

Reset Password: Click here

Contact Customer Support at

Customerservice@campaignasia.com

✓ Access limited free articles each month

✓ Email bulletins – top industry news and insights delivered straight to your inbox

✓ Unlimited access to all Campaign Asia content

✓ Real-world campaign case studies and career insights

✓ Exclusive reports, industry news, and annual features